Using Open-Source Software to Drive Reliability and Security in Lab & Life Sciences

 

Open-Source software’s flexibility through its distribution with the source code gives programmers the power to modify and distribute with its original rights. That versatility allows many technological innovations within the Health and Life Science space. Intel partners with Health and Life Science organizations on a wide range of solutions, and open-source is critical to bringing new advancements to life. 

Health and Life Science at the Edge’s Morgan Andersen welcomed Intel Product Manager Amy Gilliam and Director of Security Communications Christopher Robinson for a discussion on open-source, everything from what it is, what the culture is like, and managing the quality of the code.

Gilliam says the culture around open source has grown to become a collaborative environment that’s enhanced over the years. Open exchange, de-centralized coding collaboration and peer review are all norms that move open source in a positive direction. “Peer review is a huge part of the open-source development process, in which developers submit code, it gets reviewed by multiple team members and project members before it gets integrated into the main code base by the maintainer,” Gilliam adds. 

From Robinson’s perspective, open source thrives because of the collaboration community. “I’ve been doing security in upstream open source for just under a decade, and I get to work with people from all around the world. We used to have a concept frequently talked about; it was called meritocracy; whereas you were contributing to these communities, people would put forth other ideas, and normally the best idea will win out. After much review and conversation, you’ll generally have better quality code because you’ve had all these different types of inputs.” 

So, how does security factor into open source when privacy is critical to a lot of work done in the health and life science world? Some essential regulations and rules govern the industry to protect human life. Gilliam says technology developers must familiarize themselves with these regulations and ensure the flexibility and capability to meet those compliance requirements now and in the future. 

“The FDA requires disclosures of software submission,” Gilliam said. “So, along with those disclosures of software, are usually calling out of risks and mitigations. Those can be cybersecurity risks, privacy risks, etc. We’re monitoring for that as we’re building software and these analytical tools that will help leverage and accelerate processes in the pharmaceutical industry.” 

Learn more about Open Source solutions by connecting with Amy Gilliam and Christopher Robinson on LinkedIn or visit Intel Health and Life Sciences. 

Subscribe to this channel on Apple PodcastsSpotify, and Google Podcasts to hear more from the Intel Network and Edge Solutions Group.

Follow us on social media for the latest updates in B2B!

Image

Latest

mobile gaming
From Flip Phones to Free-to-Play Empires: How Mobile Gaming Reshaped Business Models, Communities, and Esports
September 17, 2025

Mobile gaming has quietly become the largest segment of the global gaming industry, generating about $92 billion annually—more than both PC and console games. Yet for decades, many brands and agencies underestimated its reach, focusing instead on arena-filling esports tournaments or blockbuster console titles. With nearly everyone carrying a smartphone, however, mobile has become…

Read More
Revenue Cycle
Transformation Without Disruption: How Access Healthcare Is Rewiring the Revenue Cycle with Agentic AI
September 17, 2025

Hospitals are juggling shrinking margins and rising costs while denial volumes remain stubbornly high. In the revenue cycle alone, hundreds of billions are lost annually to preventable errors and inefficiencies—in fact, Access Healthcare CEO Shaji Ravi cites more than $250 billion wasted each year. Meanwhile, payers have accelerated their use of AI to adjudicate…

Read More
leading with intention
Making Meaning Out of Life’s Pause: Billie Whitehouse on Finding Strength, Setting Boundaries, and Leading With Intention
September 17, 2025

In June, Forbes profiled Billie Whitehouse, CEO and Creative Director of Wearable X, as she broke her silence about leading through a devastating health crisis. Diagnosed with stage 4 colon cancer at 27 while 22 weeks pregnant, Whitehouse underwent emergency surgery that ensured her survival, but came with the profound heartbreak of losing her…

Read More
Critical Care
Transforming the ICU Through Technology: Advances in Critical Care Telehealth Delivering Gold-Standard Care Anywhere
September 17, 2025

Critical care in the United States faces a mounting crisis. With a shortage of board-certified intensivists and younger, less experienced nurses filling ICUs, hospitals often struggle to provide timely, gold-standard care. Studies show that hospitals with board-certified intensivists in their ICUs see a 30% reduction in patient mortality, yet thousands of facilities still lack…

Read More